Myocardial Infarction Current Events | Myocardial Infarction News | 3
|
| Page
3 of
16 |
311 Results |
|
|
|
Sort By:
Page Views | Date |
Medication does not appear to offer benefit for certain heart attack patients undergoing PCI
Use of the drug pexelizumab immediately before and for 24 hours after stent placement or angioplasty for certain heart attack patients did not have any significant treatment effect compared to placebo, according to a study in the January 3 issue of JAMA. The medication had shown promise in preliminary studies. view more (2007-01-03)
Breakthrough in national diseases: Common factor behind myocardial infarction, rheumatism and MS
A common gene variant has been identified as the risk factor behind a number of common diseases by research scientists at Karolinska Institutet and the Centre for Molecular Medicine (CMM), Stockholm, Sweden. Up to a quarter of the population could be affected. view more (2005-04-08)
Heart failure?
Aio! is a new Finnish diagnostic method for rapidly diagnosing an acute myocardial infarct when a patient with chest pains arrives at the hospital or consults a doctor. The diagnostic system Aio! has been developed by Innotrac Diagnostics Oy with the goal of rapidly and accurately identifying in a patient-friendly way the markers secreted into... view more... (2002-06-19)
ESC Congress 2004: Improvement of treatment for ST-elevation myocardial infarction in diabetics according to guidelines reduced hospital mortality in clinical practice by 36% between 1994 and 2002
Diabetes mellitus increases the risk to develop coronary artery disease by the factor two to four. Cardiovascular complications are the leading causes of morbidity and mortality in patients with diabetes. In randomized controlled trials as well as in prospective registries, diabetics with acute ST-elevation myocardial infarction (STEMI) have been... view more... (2004-08-30)
Triple antiplatelet therapy appears superior to dual antiplatelet therapy
Results of five research studies and a clinical registry first-report presentation scheduled for the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggest that triple antiplatelet therapy for patients undergoing percutaneous coronary intervention (PCI)... view more... (2008-10-14)
New target for heart failure therapy identified
A novel signaling pathway plays a significant role in the production of aldosterone, a hormone that promotes heart failure after a myocardial infarction, according to a study conducted by Thomas Jefferson University researchers. view more (2009-03-17)
Early myocardial enhancement defects on multidetector CT predicts future myocardial viability
Early myocardial enhancement defects (dark spots) on multidetector CT are valuable predictors of myocardial viability in patients who have suffered a heart attack. view more (2006-05-03)
Depression lingers for female heart attack victims
Women who have suffered heart attacks have higher rates of lingering depressive symptoms compared to their male counterparts, a University of Alberta and McGill University study shows. view more (2007-07-16)
ESC Congress 2004: Glucose Abnormalities in patients with Myocardial Infarction
This trial reveals important new information on the relation between reduced ability to handle glucose (sugar) and acute heart attacks. view more (2004-08-31)
A useful method to diagnose chest pain with foregut symptoms
Recent reports have indicated that recurrent chest pain is often a result of esophageal motility disorders or gastroesophageal reflux diseases (GERD), which is known as esophageal chest pain. view more (2009-02-19)
Healthy men who drink moderately have reduced risk of heart attack
For men with healthy lifestyle habits, drinking moderate amounts of alcohol may be associated with a lower risk of heart attack than drinking heavily or not drinking at all. view more (2006-10-24)
New research shows ACTOS is associated with a 38 percent lower risk of heart attack
New research, including two studies presented this week at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD), further support the cardiovascular safety of ACTOS (pioglitazone HCI) and its benefits regarding improved blood glucose and blood lipid levels for patients with type 2 diabetes. view more (2007-09-20)
Lipid lowering therapy reduces short-term deaths after heart attack, new findings show
New research findings published in this week’s issue of The Lancet have added more fuel to the debate over the merits of lipid lowering therapy to improve the survival chances of heart attack patients. The findings, from an international study involving investigators from USA, UK, Hungary, France and Canada, showed that patients treated for... view more... (2001-04-06)
Emergency angioplasty use rises, but some patients still miss out
Compared with their counterparts a decade ago, today's heart attack patients are receiving emergency angioplasty or clot-busting drugs to re-open clogged arteries at a far greater rate, but 10 percent of patients who could benefit from this life-saving treatment still do not receive it. view more (2007-08-03)
An ESC statement on gender differences in medical care and survival after myocardial infarction
A paper published online by the journal Circulation on 8 December 2008 concluded that, while men and women have a similar in-hospital death rate following acute myocardial infarction, women with STEMI had an adjusted mortality rate almost twice as high as men (10.2% versus 5.5%). view more (2008-12-18)
Researchers resolve how COX inhibitors cause heart hazards, and offer alternative treatment strategy
Inhibitors of cyclooxygenase-2 (COX-2) were developed to relieve inflammatory pain as effectively as nonsteroidal anti-inflammatory drugs (NSAIDS), but without one of their major side effects, gastrointestinal bleeding. view more (2006-04-14)
NEW THERAPEUTIC APPROACH TO CORONARY STENTING (p 2037)
Patients given stent implantation to treat coronary heart disease could benefit from a new therapeutic approach with the platelet glycoprotein IIb/IIIa inhibitor eptifibatide, concludes research published in this week's issue of THE LANCET. The platelet glycoprotein IIb/IIIa inhibitors are potent inhibitors of blood clotting. They have previously... view more... (2000-12-13)
Statewide program helps improve quality of care for heart attack
Implementation of a program in North Carolina to increase the rate of coronary reperfusion (restoring blood flow to the heart muscle) for heart attack significantly improved the quality of care these patients received. view more (2007-11-05)
Diabetes appears to increase risk of death for patients with acute coronary syndromes
Individuals with diabetes and acute coronary syndromes (ACS) such as a heart attack or unstable angina have an increased risk of death at 30 days and one year after ACS, compared with ACS patients without diabetes. view more (2007-08-15)
ESC Congress 2003: Watch football and die?
IMPORTANT: This press release accompanies a poster or oral session given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: Our study shows an increase in out-of-hospital sudden cardiac deaths in the adult... view more... (2003-08-31)
|
|
| Page
3 of
16 |
311 Results |
|
|
|
Sort By:
Page Views | Date |
|
